Mainline Instruments is excited to announce a new partnership with InMode, a globally recognised leader in IPL, Laser, and Radiofrequency medical technologies, to distribute their prestigious Envision Dry Eye care platform throughout the UK and Ireland.
InMode is known for its innovation in minimally invasive and non-invasive medical devices that deliver exceptional results for both patients and practices. With significant expertise in dry eye treatments, InMode has been a pioneer in developing advanced technologies to address this growing condition.
The Envision platform is a cutting-edge ophthalmic solution for non-surgical dry eye treatments. Its compact, fully programmable workstation is designed for customizable treatments in optometrist clinics. The system utilises three complementary modes of treatment with small applicators to target delicate subdermal layers in the periorbital area, offering a holistic approach to treating dry eye.
Lumecca-I: Delivers Intense Pulsed Light (IPL) to reduce the vascular inflammation to treat dry eye/ocular surface disease, offering precision and targeted spot-size treatments through the Lumecca-I adaptor.
Forma-I: Bipolar Radiofrequency (RF) is innovative thermal technology designed to deliver targeted bipolar radiofrequency (RF) energy to small delicate zones, such as the periorbital area, targeting the meibomian glands to support effective dry eye treatment, improving the quality of meibum as well as improving the aesthetic outcome by promoting collagen to help rejuvenate the periorbital area.
Morpheus8: A fractional skin treatment that stimulates the underlying layers of the dermis. By targeting the deeper layers of the skin, tissues are triggered to reveal a more radiant youthful appearance. Radiofrequency (RF) energy is a scientifically proven method to stimulate collagen. It is minimally invasive, using a matrix of micro pins to target the deeper layers of the skin with almost no patient downtime.
FURTHER INFORMATION:
Mainline Instruments
T: +44 (0)121 458 6800
E: sales@main-line.co.uk
W: www.main-line.co.uk/envision
